Prospects for the use of new epilepsy classifications to improve the quality of medical care

Disease classification is an essential system for organizing diseases, allowing for international comparison of research results, standardizing treatment and diagnostic approaches, and improving the quality of healthcare services. One of the primary classifications is the International Classification of Diseases (ICD), which is used for collecting and analyzing data on morbidity and mortality across different countries. In 2017, the International League Against Epilepsy (ILAE) updated epilepsy classification, and in 2021, the ICD was revised, including changes in the classification of epilepsy. This study aims to introduce the new epilepsy classification according to ICD-11 and analyze the changes between ICD-10 and ICD-11. The ICD plays a significant role in organizing healthcare, analy­zing epidemiological data, optimizing medical resources, and impro-ving treatment. ICD-11, introduced in 2019, incorporates the latest achievements in science and technology with significant changes in epilepsy classification and has been adapted to the ILAE 2017 epilepsy classification. The latter allows for more precise classification of seizure types and epilepsy. It includes three levels: seizure type, epilepsy type, and epileptic syndrome, with etiological factors considered at each stage, and enables the development of individualized treatment approaches, considering genetic and molecular factors. In Ukraine, epilepsy treatment protocols, which are currently used, need updating to align with modern classification standards. Transitioning to ICD-11 is promising but requires time for adaptation in clinical practice and research.